IGF2BP1 and hepatocellular carcinoma: In summary, these findings suggested that IGF2BP1 could bind to circMDK in vitro, and m6A modification enhanced the transcriptome stability of circMDK, which may partially account for the significant upregulation of circMDK in HCC.